Forefront Dermatology

Forefront Dermatology

Forefront Dermatology was built through an acquisitive strategy that targeted independent dermatology practices across the United States. Under President Betsy Wernli, the company stitched together a network of clinics — largely in the Midwest and Southeast — to create a scaled healthcare services platform. Its model mirrors other physician practice management roll-ups in specialty medicine: acquire established practices, centralize back-office and administrative functions, and leave the clinical brand largely intact at the local level. The company's deployment strategy is purely focused on healthcare services roll-ups within dermatology. Unlike diversified healthcare aggregators, Forefront concentrates on a single vertical — medical and cosmetic dermatology — and expands primarily through acquisition. The portfolio includes hundreds of clinic locations and associated pathology labs. While individual physician practice acquisitions are rarely publicly disclosed by name, the firm's growth narrative is one of cumulative bolt-on M&A, backed by private equity sponsorship. Private equity firm Varsity Healthcare Partners initially backed Forefront before selling a majority stake to OMERS Private Equity in 2018 (per PE Hub, 2018). In 2022, Partners Group acquired a controlling interest from OMERS, valuing the enterprise at roughly $1.5 billion (per Bloomberg, 2022). The firm employs hundreds of board-certified dermatologists across more than 20 states. This institutional capital backing has provided the firepower for sustained clinic-level M&A. Structurally, Forefront Dermatology represents the physician practice management (PPM) model: a corporate entity bears the operational costs and management, while physician partners typically retain minority equity and professional autonomy. The central tension — common to all PPMs — is balancing standardization with the clinical independence that attracted the physicians in the first place. Its succession of private equity sponsors reflects a classic three-stage institutional ownership arc, with each sponsor adding operational rigor and capital before passing to the next.